PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 28739753
OWN - NLM
STAT- MEDLINE
DA  - 20170725
DCOM- 20170803
LR  - 20170803
IS  - 1791-7530 (Electronic)
IS  - 0250-7005 (Linking)
VI  - 37
IP  - 8
DP  - 2017 Aug
TI  - Application of Ultrasound-guided Core Needle Biopsy in the Diagnosis of T3 or T4 
      Stage Laryngeal and Hypopharyngeal Cancer.
PG  - 4563-4567
AB  - AIM: To study the value of ultrasound-guided core needle biopsy (CNB) in the
      diagnosis of T3 or T4 stage laryngeal and hypopharyngeal cancer, which is
      difficult by routine methods. PATIENTS AND METHODS: Nineteen cases of T3 or T4
      stage laryngeal or hypopharyngeal carcinoma with abnormal pharyngeal sensitivity,
      severe dyspnea, submucous cancer recurrence, cardiovascular and pulmonary
      dysfunction were reviewed retrospectively from October 2012 to October 2014 in
      the Yuhuangding Hospital of Qingdao University. Ultrasound-guided coarse needle
      biopsies were used on primary lesions after assessing the patients with
      neck-enhanced computed tomography (CT) or magnetic resonance imaging (MRI)
      scan(s). The clinical value of ultrasound-guided CNB in the diagnosis of
      laryngeal and hypopharyngeal cancer was analyzed. RESULTS: All patients underwent
      successful pathological diagnosis by ultrasound-guided CNB without any serious
      complications. Dyspnea, cardiovascular and pulmonary dysfunction did not
      deteriorate. CONCLUSION: Ultrasound-guided CNB is a highly safe and efficient
      method for the pathological diagnosis of T3 or T4 stage laryngeal and
      hypopharyngeal cancer. It should be used especially when the fiberoptic or
      laryngoscope biopsy are of high risk.
CI  - Copyright(c) 2017, International Institute of Anticancer Research (Dr. George J. 
      Delinasios), All rights reserved.
FAU - Wang, Yunqiang
AU  - Wang Y
AD  - Department of Imaging of Head and Neck, Yuhuangding Hospital of Qingdao
      University, Yantai, P.R. China.
FAU - Li, Dajian
AU  - Li D
AD  - Department of Otorhinolaryngology and Head and Neck Surgery, Yuhuangding Hospital
      of Qingdao University, Yantai, P.R. China.
FAU - Liu, Ruihua
AU  - Liu R
AD  - Department of Ultrasonography, Yuhuangding Hospital of Qingdao University,
      Yantai, P.R. China.
FAU - Jia, Chuanliang
AU  - Jia C
AD  - Department of Otorhinolaryngology and Head and Neck Surgery, Yuhuangding Hospital
      of Qingdao University, Yantai, P.R. China.
FAU - Jiang, Aihua
AU  - Jiang A
AD  - Department of Anesthesia, Yuhuangding Hospital of Qingdao University, Yantai,
      P.R. China.
FAU - Lv, Yayun
AU  - Lv Y
AD  - Binzhou Medical University, Yantai, P.R. China.
FAU - Xu, Shufen
AU  - Xu S
AD  - Department of Otorhinolaryngology and Head and Neck Surgery, Yuhuangding Hospital
      of Qingdao University, Yantai, P.R. China.
FAU - Zhang, Hua
AU  - Zhang H
AD  - Department of Otorhinolaryngology and Head and Neck Surgery, Yuhuangding Hospital
      of Qingdao University, Yantai, P.R. China.
FAU - Cao, Xiaoli
AU  - Cao X
AD  - Department of Ultrasonography, Yuhuangding Hospital of Qingdao University,
      Yantai, P.R. China.
FAU - Song, Xicheng
AU  - Song X
AD  - Department of Otorhinolaryngology and Head and Neck Surgery, Yuhuangding Hospital
      of Qingdao University, Yantai, P.R. China [email protected]
LA  - eng
PT  - Journal Article
PL  - Greece
TA  - Anticancer Res
JT  - Anticancer research
JID - 8102988
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - *Biopsy, Large-Core Needle
MH  - Humans
MH  - Hypopharyngeal Neoplasms/*diagnosis
MH  - *Image-Guided Biopsy
MH  - Laryngeal Neoplasms/*diagnosis
MH  - Magnetic Resonance Imaging
MH  - Male
MH  - Middle Aged
MH  - Neoplasm Staging
MH  - Risk Factors
MH  - Tomography, X-Ray Computed
MH  - *Ultrasonography
OTO - NOTNLM
OT  - Laryngeal cancer
OT  - biopsy
OT  - core needle
OT  - hypopharyngeal cancer
OT  - ultrasound
EDAT- 2017/07/26 06:00
MHDA- 2017/08/05 06:00
CRDT- 2017/07/26 06:00
PHST- 2017/05/02 [received]
PHST- 2017/05/28 [revised]
PHST- 2017/05/30 [accepted]
AID - 37/8/4563 [pii]
PST - ppublish
SO  - Anticancer Res. 2017 Aug;37(8):4563-4567.